Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Jaguarhealth.gcs-web.com save search
Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index
Published: 2022-05-23 (Crawled : 12:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 3.18%
H: 1.76%
C: -3.74%
care index health cancer
Media Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!
Published: 2022-05-17 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 0.0%
H: 5.05%
C: 4.2%
media health cancer
TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
Published: 2022-05-11 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -3.65%
H: 5.08%
C: 2.81%
report health
Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
Published: 2022-05-05 (Crawled : 20:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -1.08%
H: 3.17%
C: -2.85%
health
Jaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs
Published: 2022-05-03 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 2.18%
H: 2.17%
C: -0.41%
drug diarrhea health approval
UPDATED RELEASE: Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
Published: 2022-05-05 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -6.67%
H: 0.0%
C: 0.0%
health
Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-05-06 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
| Email alert
Add to watchlist
nasdaq grant health employee
Jaguar Animal Health Announces Commercial Availability of Plant-based Canalevia-CA1 (Crofelemer) Prescription Drug for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Published: 2022-04-27 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 1.12%
H: 6.67%
C: 5.8%
treatment drug diarrhea health
Jaguar Animal Health to Host Dinner & Tableside Discussion for U.S. Veterinary Oncologists About Chemotherapy-Induced Diarrhea (CID) in Dogs on April 12th, the Final Day of the Veterinary Cancer Society (VCS) Mid-Year Conference in Puerto Vallarta, Mexico
Published: 2022-04-06 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -1.14%
H: 1.51%
C: -7.37%
day veterinary conference diarrhea health cancer
UPDATED RELEASE: Jaguar Health Enters Exclusive Crofelemer Revenue Sharing Distribution and License Agreement with Quadri Pharmaceuticals Store for Multiple Target Indications in Middle East Markets
Published: 2022-04-01 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -4.62%
H: 0.58%
C: -6.76%
health distribution license crofelemer store
Jaguar Health Shares Replay Link for March 14, 2022, Investor Webcast
Published: 2022-03-14 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -4.99%
H: 7.69%
C: -3.26%
health
Jaguar Health Provides Company Updates and Reports 2021 Financials
Published: 2022-03-11 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
| Email alert
Add to watchlist
health als report
Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, March 6th, During the Western Veterinary Conference (WVC) in Las Vegas
Published: 2022-03-01 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 2.72%
H: 10.71%
C: 0.45%
veterinarians day treatment health conference diarrhea therapy
Jaguar Animal Health Seeks MUMS Designation from FDA for Canalevia (Crofelemer) for Treatment of Exercise-induced Diarrhea (EID) in Dogs
Published: 2022-02-16 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -0.76%
H: 1.54%
C: -3.29%
treatment fda health diarrhea crofelemer designation
Jaguar Health Completes Final Major Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in Dogs
Published: 2022-02-10 (Crawled : 16:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -0.76%
H: 0.75%
C: -8.75%
health drug approval diarrhea crofelemer
Jaguar Health Announces Appointment of Martire Particco, MD, as Chief Medical Officer of Napo Therapeutics
Published: 2022-01-24 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -8.79%
H: 6.0%
C: 3.7%
health ces therapeutics
Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, January 16th During the Veterinary Meeting & Expo (VMX) Conference in Orlando, Florida
Published: 2022-01-12 (Crawled : 16:20) - jaguarhealth.gcs-web.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 0.0%
H: 0.0%
C: 0.0%
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 12.9%
H: 0.0%
C: 0.0%
veterinarians treatment health conference diarrhea therapy
Jaguar Health Announces FDA Conditional Approval of Canalevia-CA1 (Crofelemer), the First and Only Treatment for Chemotherapy-Induced Diarrhea (CID) in Dogs to Receive Any Type of Approval from FDA
Published: 2021-12-21 (Crawled : 20:20) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -7.25%
H: 3.91%
C: -7.81%
treatment fda health approval diarrhea therapy crofelemer
Jaguar Health’s Subsidiary Napo EU Changes Name to Napo Therapeutics, Reflecting the Italian Company’s Focus on Rare Diseases & Orphan Drugs
Published: 2021-12-20 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: 2.8%
H: 6.36%
C: 4.55%
health drug therapeutics disease orphan drug rare
European Medicines Agency Grants Orphan Drug Designation for Crofelemer to Napo EU, Jaguar Health’s Italian Subsidiary, for Short Bowel Syndrome
Published: 2021-12-13 (Crawled : 14:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1691 -6.0% -6.39% 38M
|
Health Technology
|
| O: -13.48%
H: 0.0%
C: 0.0%
health europe drug orphan drug syndros crofelemer granted grant designation
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.